FDA News
🇺🇸 FDA Page 15FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 169–180 of 391 articles
DCAT Week 2024: Strategic Imperatives for Pharma BD and Investors
FDA · 8 min
Dr. Sarah MitchellFDA Leadership Vacuum: Navigating Uncertainty for Pharmaceutical Business Development
FDA · 9 min
Dr. Sarah MitchellBMS-Hengrui $15B Deal: Strategic Implications for Pharma Executives
FDA · 10 min
Dr. Sarah MitchellFDA Cracks Down on Illegal Tobacco Products Disguised as Everyday Items
FDA · 8 min
Dr. Sarah MitchellBiogen Faces Italian Antitrust Probe: What It Means for the Multiple Sclerosis Market
FDA · multiple sclerosis · 10 min
Dr. Sarah MitchellFDA Draft Guidance Slashes Biosimilar PK Study Costs, Accelerating Market Entry
FDA · 6 min
Dr. Sarah MitchellEli Lilly Dominates Pharma R&D Performance Rankings, Setting New Benchmarks
FDA · 8 min
Dr. Sarah MitchellEli Lilly's Strategic Vaccine Acquisitions: A New Era in Infectious Disease
FDA · vaccine · 6 min
Dr. Sarah MitchellTrumpRx Expands Generic Drug Offerings: Implications for Pharma BD and Investors
FDA · 10 min
Dr. Sarah MitchellSupreme Court Upholds Medicare Drug Price Negotiation: Implications for Pharma
FDA · 8 min
Dr. Sarah MitchellLongeveron Stockholder Letter Outlines 2026 Strategy and Partnership Focus
FDA · 6 min
Dr. Sarah MitchellCitius Pharmaceuticals Stock Update: Cancer and Anti-Infective Pipeline Insights
FDA · cancer · 11 min
Dr. Sarah MitchellExplore intelligence